Literature DB >> 23232185

Altered Ca(2+) signaling in cancer cells: proto-oncogenes and tumor suppressors targeting IP3 receptors.

Haidar Akl1, Geert Bultynck.   

Abstract

Proto-oncogenes and tumor suppressors critically control cell-fate decisions like cell survival, adaptation and death. These processes are regulated by Ca(2+) signals arising from the endoplasmic reticulum, which at distinct sites is in close proximity to the mitochondria. These organelles are linked by different mechanisms, including Ca(2+)-transport mechanisms involving the inositol 1,4,5-trisphosphate receptor (IP3R) and the voltage-dependent anion channel (VDAC). The amount of Ca(2+) transfer from the endoplasmic reticulum to mitochondria determines the susceptibility of cells to apoptotic stimuli. Suppressing the transfer of Ca(2+) from the endoplasmic reticulum to the mitochondria increases the apoptotic resistance of cells and may decrease the cellular responsiveness to apoptotic signaling in response to cellular damage or alterations. This can result in the survival, growth and proliferation of cells with oncogenic features. Clearly, proper maintenance of endoplasmic reticulum Ca(2+) homeostasis and dynamics including its links with the mitochondrial network is essential to detect and eliminate altered cells with oncogenic features through the apoptotic pathway. Proto-oncogenes and tumor suppressors exploit the central role of Ca(2+) signaling by targeting the IP3R. There are an increasing number of reports showing that activation of proto-oncogenes or inactivation of tumor suppressors directly affects IP3R function and endoplasmic reticulum Ca(2+) homeostasis, thereby decreasing mitochondrial Ca(2+) uptake and mitochondrial outer membrane permeabilization. In this review, we provide an overview of the current knowledge on the proto-oncogenes and tumor suppressors identified as IP3R-regulatory proteins and how they affect endoplasmic reticulum Ca(2+) homeostasis and dynamics.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23232185     DOI: 10.1016/j.bbcan.2012.12.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  43 in total

Review 1.  TMBIM-mediated Ca2+ homeostasis and cell death.

Authors:  Qun Liu
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-01-05       Impact factor: 4.739

Review 2.  Bcl-2 proteins and calcium signaling: complexity beneath the surface.

Authors:  T Vervliet; J B Parys; G Bultynck
Journal:  Oncogene       Date:  2016-03-14       Impact factor: 9.867

3.  Altered purinergic receptor-Ca²⁺ signaling associated with hypoxia-induced epithelial-mesenchymal transition in breast cancer cells.

Authors:  Iman Azimi; Hannah Beilby; Felicity M Davis; Daneth L Marcial; Paraic A Kenny; Erik W Thompson; Sarah J Roberts-Thomson; Gregory R Monteith
Journal:  Mol Oncol       Date:  2015-09-25       Impact factor: 6.603

4.  Immunolocalization of IP3R and V-ATPase in Ameloblastomas.

Authors:  Allan Fernando Giovanini; Thaynara Fernanda Priesnitz; Bruna Til; Gisele Reisdoerfer; Tuanny Carvalho de Lima do Nascimento; Bernardo Sobreiro; Adriane Sousa de Siqueira; João de Jesus Viana Pinheiro
Journal:  Head Neck Pathol       Date:  2019-06-10

Review 5.  The role of the mitochondrial calcium uniporter (MCU) complex in cancer.

Authors:  Adina Vultur; Christine S Gibhardt; Hedwig Stanisz; Ivan Bogeski
Journal:  Pflugers Arch       Date:  2018-06-21       Impact factor: 3.657

6.  The Bcl-2 protein family member Bok binds to the coupling domain of inositol 1,4,5-trisphosphate receptors and protects them from proteolytic cleavage.

Authors:  Jacqualyn J Schulman; Forrest A Wright; Thomas Kaufmann; Richard J H Wojcikiewicz
Journal:  J Biol Chem       Date:  2013-07-24       Impact factor: 5.157

Review 7.  Targeting Bcl-2-IP3 receptor interaction to treat cancer: A novel approach inspired by nearly a century treating cancer with adrenal corticosteroid hormones.

Authors:  Clark W Distelhorst
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2018-07-25       Impact factor: 4.739

Review 8.  The type 2 inositol 1,4,5-trisphosphate receptor, emerging functions for an intriguing Ca²⁺-release channel.

Authors:  Tamara Vervloessem; David I Yule; Geert Bultynck; Jan B Parys
Journal:  Biochim Biophys Acta       Date:  2014-12-10

9.  The BRCA1 tumor suppressor binds to inositol 1,4,5-trisphosphate receptors to stimulate apoptotic calcium release.

Authors:  Serena C Hedgepeth; M Iveth Garcia; Larry E Wagner; Ana M Rodriguez; Sree V Chintapalli; Russell R Snyder; Gary D V Hankins; Beric R Henderson; Kirsty M Brodie; David I Yule; Damian B van Rossum; Darren Boehning
Journal:  J Biol Chem       Date:  2015-02-02       Impact factor: 5.157

10.  Induction of autophagy by valproic acid enhanced lymphoma cell chemosensitivity through HDAC-independent and IP3-mediated PRKAA activation.

Authors:  Meng-Meng Ji; Li Wang; Qin Zhan; Wen Xue; Yan Zhao; Xia Zhao; Peng-Peng Xu; Yang Shen; Han Liu; Anne Janin; Shu Cheng; Wei-Li Zhao
Journal:  Autophagy       Date:  2015       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.